1 / 14

KP6 Initiative: Network of Excellence

KP6 Initiative: Network of Excellence European Network to Promote Research into Uncommon Cancers in Adults and Children: Pathology, Biology, and Genetics of Bone Tumours . Research topic addressed.

macy
Télécharger la présentation

KP6 Initiative: Network of Excellence

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. KP6 Initiative: Network of Excellence European Network to Promote Research into Uncommon Cancers in Adults and Children: Pathology, Biology, and Genetics of Bone Tumours

  2. Research topic addressed • Establishing facilities and developing initiatives for the exploitation of research on bone cancer in Europe • Encouraging the development of evidence based guidelines for good clinical practice and improved public health strategies by accelerating the translation of existing research results into applications • Supporting translational research aimed at bringing basic knowledge through to applications in clinical practice and public health

  3. EuroBoNeT • 12 countries • 24 participants • Kick off 8-02-2006

  4. Integration objectives • Training and education • Standardisation in technology • Share of material • Web based sharing of information and communication • Translational research

  5. Spreading excellence objectives Coordinated by Treviso • Courses on bone pathology and molecular biology • Standard Operation Protocols • Web-based discussion forums

  6. Strategic objectives • Cross-discipline research on bone tumours • expertise • technology • numbers of material • Integrating dispersed skills • Integrating technology • Collaboration with small and intermediate sized companies • specialised in making technology available for direct standardised research and clinical usage

  7. Research objectives • Work packages on: Cartilaginous Tumours (Leiden) Osteogenic Tumours (Munster) Giant Cell Tumours (Oxford) Ewing Sarcoma (Bologna)

  8. Cartilaginous Tumours • Biology of central and peripheral chondrosarcoma • Benign cartilage tumours as a model for cartilage differentiation • Multiple osteochondromas (MO) • In vitro models of cartilage and bone differentiation in comparison with bone and cartilage neoplasia. Chondrocyte cell biology: Mortality and immortality & Mesenchymal stem cell differentiation

  9. Osteogenic Tumours • Biology and genetics of osteosarcoma • Drugresponse and pharmacogenomics in osteosarcoma • Osteolytic malignant lesions; improvement of knowledge on MFH, fibrosarcoma and chordoma

  10. Giant Cell Tumours • Biology of giant cell tumours of bone • Molecular mechanisms of osteoclastogenesis • Paget's diseaseof bone and secondary sarcomas

  11. Ewing Sarcoma • Biology of Ewing sarcoma • Immunotherapy of Ewing sarcoma • Drugresponse, pharmacogenomics and targeted therapy in Ewing sarcoma

  12. G. Bacci

  13. Key partners are represented by • Soft tissue and Bone Pathology group of the EORTC/EOI • Bone and Soft Tissue Working group of the European society of Pathology (ESP) • International Society of Bone and Soft Tissue Pathology • Connective Tissue Oncology Society (CTOS) • European Muscle Skeletal Oncologic Society (EMSOS) • International Skeletal Society (ISS)

  14. Time Line for Kick Off • Draft final Contract 10.02.2006 • Contract Signature 22.02.2006 • Contract start 01.02.2006

More Related